Where magnesium bisglycinate is permitted, and what the file must show
Four questions decide whether a magnesium bisglycinate lot can be sold into a market: whether the form is permitted, whether the contaminants are inside the limit, whether the label names the form correctly, and whether the claims made for it are authorised. The answers differ by market, and a page that answers only one of them is not a compliance page.
The permitted form, the contaminant limit and the label rule are three different questions, and each has a different answer by market.
The four checks
The first check is the permitted-form list. The European Union publishes a list of vitamin and mineral substances that may be used in food supplements; the United States approaches the same question through the dietary-ingredient provisions of DSHEA; the United Kingdom keeps a retained version of the EU list. A form that is permitted in one market is not automatically permitted in another.
The second check is the contaminant limit. Lead, cadmium, mercury and arsenic are the usual panel, but the legal basis and the numeric limit differ. The third check is the label: the ingredient must be named in the form the law expects, and the elemental magnesium must be declared in the required way. The fourth check is the claim: an authorised health claim, a structure/function statement and a therapeutic claim are three different categories with three different rules.
European Union
Magnesium bisglycinate is listed in Annex II of Directive 2002/46/EC, the list of vitamin and mineral substances that may be used in the manufacture of food supplements. The listing is the first gate, not the whole answer. The Member State notification procedure, the contaminant limits in Regulation (EU) 2023/915 and the labelling rules in Regulation (EU) No 1169/2011 all apply on top of it.
The contaminant limits for food supplements are set per kilogram of the product as sold. Lead is limited to 3.0 mg/kg, cadmium to 1.0 mg/kg and mercury to 0.10 mg/kg; arsenic is not harmonised at EU level, so a Member State may apply its own limit. The full table is on the EU compliance page.
United States
In the United States, magnesium bisglycinate is sold as a dietary ingredient under DSHEA. The exact form has to be a lawful dietary ingredient: it may be grandfathered, it may be the subject of a GRAS conclusion for the intended use, or it may require a new dietary ingredient notification. The basis should be documented by the supplier, not assumed from the fact that magnesium is an essential nutrient.
There is no USP monograph for magnesium bisglycinate, so a “USP-grade” claim needs a specific reference and a batch declaration; the absence of a monograph is not a defect, but it means the specification is the buyer's own. The Supplement Facts panel declares elemental magnesium against the Daily Value of 420 mg for adults and children four years and older. The full label and claims position is on the US compliance page.
The contaminant table
| Element | EU | US | UK |
|---|---|---|---|
| Lead | 3.0 mg/kg | No federal limit specific to supplements; state rules apply | Retained EU limit, checked against UK law |
| Cadmium | 1.0 mg/kg | No federal limit specific to supplements | Retained EU limit |
| Mercury | 0.10 mg/kg | No federal limit specific to supplements | Retained EU limit |
| Arsenic | Not harmonised; Member State rules may apply | No federal limit specific to supplements | Checked against UK law |
The table is a starting point, not legal advice. California Proposition 65 sets a maximum allowable dose level of 0.5 µg/day for lead (reproductive toxicity) and a no-significant-risk level of 15 µg/day (cancer), so a product that is inside the EU limit can still trigger a California warning at a low daily dose. The destination and the dose have to be checked together.
Claims
In the EU, magnesium claims are authorised in Regulation (EU) No 432/2012 and may be used only under the conditions attached to each claim. The claims describe a contribution to normal function; they are not disease claims. In the US, a structure/function statement is the brand's responsibility, must be truthful and substantiated, and must carry the DSHEA disclaimer. Neither market allows a therapeutic or disease-related claim for the ingredient.
This site does not make either kind of claim. It publishes the specification and the regulatory framework; the claim belongs to the brand that puts it on the label and to the market that authorises it.
The document pack
- Batch COA with the magnesium, glycine, moisture and contaminant results.
- Specification and technical data sheet naming the form and hydrate state.
- Safety data sheet in the 16-section format.
- Allergen, GMO, origin and residual-solvent statements.
- Statement of the legal basis for the dietary-ingredient status in the US, where applicable.
- Certificate of analysis from a third-party laboratory, where the buyer's review requires one.
What to check before the first order
- Is the exact form permitted in the destination market, and is the hydrate state named?
- Do the contaminant results cover the destination limit and the daily dose?
- Does the label name every magnesium source in the drum?
- Is the claim authorised, or is it a structure/function statement with the required disclaimer?
- Does the supplier's document pack include the legal basis for the ingredient status?
The EU page and the US page expand the two markets this site ships to most often. The quality page describes how the batch file is assembled.
In this document
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation